DBV DBV Technologies SA

Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2020

Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2020

Monthly information regarding the total number of voting rights and 

total number of shares of the Company as of December 31, 2020

(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Market : NYSE Euronext Paris

ISIN Code: FR 0010417345

 



Date



 		Total number of shares Total number of voting rights
12/31/202054,929,187 



Total gross of voting rights: 54,929,187



 
 



Total net* of voting rights:  54,816,885



 

* Total net = total number of voting rights attached to shares – shares without voting rights

Attachment



EN
05/01/2021

Underlying

DBVDBV Technologies SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DBV Technologies SA

 PRESS RELEASE
Free
DBV DBV Technologie...

DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq

DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq Châtillon, France, September 5, 2025 DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: DBVT) (the “Company”), a clinical-stage biopharmaceutical company, today announced that it has filed a prospectus supplement with the U.S. Securities and Exchange Commission (“SEC”) relating to an at-the-market offering (the “ATM Program”). Pursuant to this new financing program, the Company may offer and sell, including with unsolicited ...

September 5, 2025 1 EN
 PRESS RELEASE
Free
DBV DBV Technologie...

DBV Technologies met en place un Programme At-The-Market (ATM) sur le ...

DBV Technologies met en place un Programme At-The-Market (ATM) sur le Nasdaq Châtillon, France, le 5 septembre (22:30 CEST) 2025 DBV Technologies met en place un Programme At-The-Market (ATM) sur le Nasdaq DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Capital Market : DBVT) (la « Société »), une société biopharmaceutique au stade clinique, a annoncé ce jour l’enregistrement d’un supplément au prospectus (« prospectus supplement ») auprès de la U.S. Securities and Exchange Commission (la « SEC ») aux Etats-Unis dans le cadre de la mise en place d’un programme de fina...

September 5, 2025 1 EN
 PRESS RELEASE
Free
DBV DBV Technologie...

DBV Technologies to Participate in the H.C. Wainwright 27th Annual Glo...

DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference Châtillon, France, September 3, 2025 DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, today announced that Daniel Tassé, Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 27th Annual Global Investment Conference on Tuesday, September 9, 2025, at 11:30am ET, in New York, N...

September 3, 2025 1 EN
 PRESS RELEASE
Free
DBV DBV Technologie...

DBV Technologies participera à la 27e conférence annuelle H.C. Wainwri...

DBV Technologies participera à la 27e conférence annuelle H.C. Wainwright Global Investment Châtillon, France, le 3 septembre (22:30 CEST) 2025 DBV Technologies participera à la 27e conférence annuelle H.C. Wainwright Global Investment DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP : 23306J309), une société biopharmaceutique au stade clinique a annoncé aujourd'hui que Daniel Tassé, Directeur Général, participera à une discussion « fireside chat » lors de la 27e conférence annuelle H.C. Wainwright Global Investment, le mardi 9 septembre 2025 à ...

September 3, 2025 1 EN
Damien Choplain ... (+3)
  • Damien Choplain
  • Maria Vara
  • Oscar Haffen Lamm
EVT EVOTEC SE
DBV DBV Technologie... ... (+3)

End of coverage

From 5th August 2025, we will no longer include the following companies in our coverage:EVOTECMEDIOSDBV Technologies

EVT EVOTEC SE
DBV DBV TECHNOLOGIES SA
ILM1 MEDIOS
08/05/25 August 5, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch